BBSRC Portfolio Analyser
Award details
Technical development of a novel vaccine vehicle for cattle pathogens
Reference
BB/L02442X/1
Principal Investigator / Supervisor
Professor Keith Matthews
Co-Investigators /
Co-Supervisors
Institution
University of Edinburgh
Department
Sch of Biological Sciences
Funding type
Research
Value (£)
305,156
Status
Completed
Type
Research Grant
Start date
27/10/2014
End date
21/04/2017
Duration
30 months
Abstract
unavailable
Summary
Trypanosoma theileri is a ubiquitous single celled organism present in cattle herds worldwide. Using knowledge of gene expression and protein trafficking in other trypanosomatid organisms, we have successfully developed T. theileri as a delivery system for vaccine antigens and therapeutics. Following recommendations from several Animal Health companies, we now aim to develop and demonstrate the potential of T. theileri as an effective and practical vaccine-vehicle, providing a clear route to commercialisation. In a two-step development path, Phase 1 will focus on technical refinements and analysis of the viability of the vaccine-vehicle during storage and distribution. The flexibility of the system to express antigens from a range of pathogens will also be established. Phase 2 will entail confirmation of the in vivo efficacy of the refinements developed in Phase 1. Combined the experiments will address key hurdles to the commercial development of this patented vaccine system.
Committee
Not funded via Committee
Research Topics
Animal Health, Immunology, Microbiology
Research Priority
X – Research Priority information not available
Research Initiative
Follow-On Fund Super (SuperFOF) [2012-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search